ACM Global Central Laboratory Names New Vice President of Scientific Affairs and Laboratory Operations at US Facility

ROCHESTER, N.Y. (January 28, 2014) ACM Global Central Laboratory (ACM Global), a diagnostic central laboratory specializing in delivering high quality testing services which optimize clinical trial outcomes, is proud to announce that Mary Williamson, MT (ASCP), PhD has been promoted to the new position of Vice President, Scientific Affairs and Laboratory Operations. In this new role, Dr. Williamson will serve as the primary scientific intermediary for our Clinical Trials and Medical Diagnostic businesses, responsible for defining client testing requirements, aligning ACM’s technical capabilities and resources globally to meet our clients’ needs, and ongoing development of ACM’s diagnostic test offerings. Dr. Williamson will act as the scientific liaison with our partner and reference laboratories, and will lead our efforts to harmonize and standardize processes and key metrics across all global ACM laboratory operations. She will also play a lead role in developing our longer-term strategy for investments to expand our scientific capabilities.

Dr. Williamson received her BS degree in Clinical Laboratory Sciences from SUNY at Stony Brook, NY, and her MS d and PhD degrees in Toxicology from the University of Rochester. She is a board certified Clinical Chemist (NRCC) and Medical Technologist (ASCP). Dr. Williamson has been with ACM since November 2010 serving as the Executive Director of Laboratory Operations. Prior to joining ACM, she served as the Senior Director of Laboratory Operations and Point of Care Services at the UMASS Memorial Medical Center in Worcester, Massachusetts where she also held academic appointments at the University of Massachusetts and Boston University. Her current professional and academic endeavors include Chair of the Unity Hospital IRB Board, Laboratory Director of the Monroe County STD Clinic as well as the senior editor and coauthor of the 9th & 10th editions of “Wallach’s Interpretation of Diagnostic Tests,” a medical textbook published internationally.

Angela Panzarella, President of ACM Medical Laboratory, remarked: “We are very pleased to have Dr. Williamson provide key scientific leadership to ACM as we continue developing our capabilities and expanding our horizons. Her knowledge and expertise are crucial ingredients in successfully growing our global capabilities to better serve our clients.”

About ACM Global Central Laboratory
ACM Global Central Laboratory specializes in delivering high quality central laboratory testing services designed to optimize clinical trial outcomes. Through a powerful combination of robust global capabilities, operational and scientific expertise and unsurpassed service, ACM Global acts as an extension of our clients’ clinical teams to develop and execute Smarter Testing strategies that deliver reliable outcomes for their clinical development programs. Operating in more than 60 countries, ACM Global’s analytical team performs more than 15 million diagnostic tests each year from a test menu with more than 1,500 tests spanning all medical disciplines, including pathology, microbiology and molecular diagnostics, flow cytometry, specialized biomarkers, and pharmacogenomics.

For more information, visit www.acmgloballab.com, our Central Labs in Focus blog or call +1 866 405 0400.

email us at: info@acmgloballab.com
© ACM Global Laboratories 2017.
All rights reserved

HIPAA Privacy Statement